Kusuri No Aoki Holdings Co., Ltd. (TYO:3549)
Japan · Delayed Price · Currency is JPY 4,221.00
+54.00 (1.30%)
Aug 7, 2025, 9:45 AM JST
Kusuri No Aoki Holdings Revenue
In the fiscal year ending May 20, 2025, Kusuri No Aoki Holdings had annual revenue of 501.47B JPY with 14.79% growth. Kusuri No Aoki Holdings had revenue of 129.59B in the quarter ending May 20, 2025, with 17.63% growth.
Revenue
501.47B
Revenue Growth
+14.79%
P/S Ratio
0.84
Revenue / Employee
105.91M
Employees
4,735
Market Cap
419.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 20, 2025 | 501.47B | 64.60B | 14.79% |
| May 20, 2024 | 436.88B | 58.00B | 15.31% |
| May 20, 2023 | 378.87B | 50.54B | 15.39% |
| May 20, 2022 | 328.34B | 22.46B | 7.34% |
| May 20, 2021 | 305.88B | 5.71B | 1.90% |
| May 20, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 20, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 20, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 20, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Daiichi Sankyo Company | 1,924.68B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,036.17B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |